Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins

European Journal of Pharmacology

Volumn 650, Issue 2-3, 2011, Pages 501-510

  Keith, Dove J ^a,d   Eshleman, Amy J ^a,b   Janowsky, Aaron ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Dopamine receptor; Dopamine transporter; Endocytosis; Phospholipase

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ARACHIDONIC ACID; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; FATTY ACID; MELITTIN; MEMBRANE PROTEIN; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C INHIBITOR; PHOSPHOLIPASE D INHIBITOR; PHOSPHOLIPASE INHIBITOR; SPIPERONE; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; FAT CONTENT; FATTY ACID TRANSPORT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; BIOLOGICAL TRANSPORT; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG INTERACTIONS; ENZYME ACTIVATORS; HEK293 CELLS; HUMANS; MELITTEN; MEMBRANE PROTEINS; PHOSPHOLIPASE D; PHOSPHOLIPASES; PHOSPHOLIPASES A2; PROTEIN TRANSPORT; TYPE C PHOSPHOLIPASES;

EID: 78651085635     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.023     Document Type: Article

References (58)

1. A.P. Albert, A.S. Piper, and W.A. Large Role of phospholipase D and diacylglycerol in activating constitutive TRPC-like cation channels in rabbit ear artery myocytes J. Physiol. 566 2005 769 780
2. A.W. Bernheimer, and B. Rudy Interactions between membranes and cytolytic peptides Biochim. Biophys. Acta 864 1986 123 141
3. D.H. Carney, D.L. Scott, E.A. Gordon, and E.F. LaBelle Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation Cell 42 1985 479 488
4. C. Chatterjee, and C. Mukhopadhyay Melittin-GM1 interaction: a model for a side-by-side complex Biochem. Biophys. Res. Commun. 292 2002 579 585
5. C.A. Chen, and H. Okayama Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA Biotechniques 6 1988 632 638
6. N. Chen, M. Appell, J.L. Berfield, and M.E. Reith Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter Eur. J. Pharmacol. 478 2003 89 95
7. J. Cuppoletti, and A.J. Abbott Interaction of melittin with the (Na+ + K+)ATPase: evidence for a melittin-induced conformational change Arch. Biochem. Biophys. 283 1990 249 257
8. G.M. Daniels, and S.G. Amara Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters J. Biol. Chem. 274 1999 35794 35801
9. L.C. Daws, P.D. Callaghan, J.A. Moron, K.M. Kahlig, T.S. Shippenberg, J.A. Javitch, and A. Galli Cocaine increases dopamine uptake and cell surface expression of dopamine transporters Biochem. Biophys. Res. Commun. 290 2002 1545 1550
10. D.G. Demuth, E. Gkoumassi, M.J. Droge, B.G. Dekkers, H.J. Esselink, R.M. van Ree, M.E. Parsons, J. Zaagsma, A. Molleman, and S.A. Nelemans Arachidonic acid mediates non-capacitative calcium entry evoked by CB1-cannabinoid receptor activation in DDT1 MF-2 smooth muscle cells J. Cell. Physiol. 205 2005 58 67
11. E.A. Dennis Diversity of group types, regulation, and function of phospholipase A2 J. Biol. Chem. 269 1994 13057 13060
12. A.J. Eshleman, R.L. Neve, A. Janowsky, and K.A. Neve Characterization of a recombinant human dopamine transporter in multiple cell lines J. Pharmacol. Exp. Ther. 274 1995 276 283
13. A.J. Eshleman, M. Carmolli, M. Cumbay, C.R. Martens, K.A. Neve, and A. Janowsky Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type J. Pharmacol. Exp. Ther. 289 1999 877 885
14. W.A. Fairman, M.S. Sonders, G.H. Murdoch, and S.G. Amara Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4 Nat. Neurosci. 1 1998 105 113
15. 2 and secondary metabolites of arachidonic acid control filopodial behavior in neuronal growth cones Cell Motil. Cytoskeleton 57 2004 53 67
16. K.B. Glaser, D. Mobilio, J.Y. Chang, and N. Senko Phospholipase A2 enzymes: regulation and inhibition Trends Pharmacol. Sci. 14 1993 92 98
17. J.R. Gledhill, and J.E. Walker Inhibition sites in F1-ATPase from bovine heart mitochondria Biochem. J. 386 2005 591 598
18. H.J. Han, S.H. Park, J.H. Lee, B.C. Yoon, K.M. Park, W.C. Mar, H.J. Lee, and S.K. Kang Involvement of oxidative stress in bee venom-induced inhibition of Na+/glucose cotransporter in renal proximal tubule cells Clin. Exp. Pharmacol. Physiol. 29 2002 564 568
19. T. Higashijima, S. Uzu, T. Nakajima, and E.M. Ross Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins) J. Biol. Chem. 263 1988 6491 6494
20. D.F. Horrobin, A.I. Glen, and K. Vaddadi The membrane hypothesis of schizophrenia Schizophr. Res. 13 1994 195 207
21. S.L. Ingram, and S.G. Amara Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter J. Neurosci. 20 2000 550 557
22. D.M. Kurrasch-Orbaugh, V.J. Watts, E.L. Barker, and D.E. Nichols Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves J. Pharmacol. Exp. Ther. 304 2003 229 237
23. S.Y. Lee, H.S. Park, S.J. Lee, and M.U. Choi Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: lack of selective activation of phospholipase A2 by melittin Arch. Biochem. Biophys. 389 2001 57 67
24. L.J. Lefkowitz, and W.J. Smith Sulfur mustard-induced arachidonic acid release is mediated by phospholipase D in human keratinocytes Biochem. Biophys. Res. Commun. 295 2002 1062 1067
25. M. L'hirondel, A. Cheramy, G. Godeheu, and J. Glowinski Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat J. Neurochem. 64 1995 1406 1409
26. L.E. Limbird Cell Surface Receptors: A Short Course on Theory and Methods 2005 Springer Science + Business Media Inc
27. K.Y. Little, L.W. Elmer, H. Zhong, J.O. Scheys, and L. Zhang Cocaine induction of dopamine transporter trafficking to the plasma membrane Mol. Pharmacol. 61 2002 436 445
28. L.E. MacDonell, F.K. Skinner, P.E. Ward, A.I. Glen, A.C. Glen, D.J. Macdonald, R.M. Boyle, and D.F. Horrobin Increased levels of cytosolic phospholipase A2 in dyslexics Prostaglandins Leukot. Essent. Fatty Acids 63 2000 37 39
29. J.E. Mahaney, J. Kleinschmidt, D. Marsh, and D.D. Thomas Effects of melittin on lipid-protein interactions in sarcoplasmic reticulum membranes Biophys. J. 63 1992 1513 1522
30. Y. Maulet, and J.A. Cox Structural changes in melittin and calmodulin upon complex formation and their modulation by calcium Biochemistry 22 1983 5680 5686
31. R. Mehvar, and D.R. Brocks Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans J. Pharm. Sci. 4 2001 185 200
32. I.A. Muzzio, C.C. Gandhi, U. Manyam, A. Pesnell, and L.D. Matzel Receptor-stimulated phospholipase A(2) liberates arachidonic acid and regulates neuronal excitability through protein kinase C J. Neurophysiol. 85 2001 1639 1647
33. H. Nakamura, T. Hirabayashi, A. Someya, M. Shimizu, and T. Murayama Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine Eur. J. Pharmacol. 484 2004 9 17
34. K.A. Neve, R.A. Henningsen, J.R. Bunzow, and O. Civelli Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line Mol. Pharmacol. 36 1989 446 451
35. L. Palomba, M. Bianchi, T. Persichini, M. Magnani, M. Colasanti, and O. Cantoni Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid Free Radic. Biol. Med. 36 2004 319 329
36. H.J. Park, S.H. Lee, D.J. Son, K.W. Oh, K.H. Kim, H.S. Song, G.J. Kim, G.T. Oh, D.Y. Yoon, and J.T. Hong Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit Arthritis Rheum. 50 2004 3504 3515
37. L.H. Parsons, and J.B. Justice Jr. Quantitative approaches to in vivo brain microdialysis Crit. Rev. Neurobiol. 8 1994 189 220
38. D. Piomelli Arachidonic Acid Psychopharmacology: The fourth generation of progress: An official publication of the American College of Neuropsychopharmacology 1995 Lippincott Williams Wilkins
39. D. Piomelli, C. Pilon, B. Giros, P. Sokoloff, M.P. Martres, and J.C. Schwartz Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism Nature 353 1991 164 167
40. H. Raghuraman, and A. Chattopadhyay Melittin: a membrane-active peptide with diverse functions Biosci. Rep. 27 2007 189 223
41. J.H. Rapp, W.E. Connor, D.S. Lin, T. Inahara, and J.M. Porter Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression J. Lipid Res. 24 1983 1329 1335
42. M.S. Reid, K. Hsu, B.K. Tolliver, C.A. Crawford, and S.P. Berger Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization J. Pharmacol. Exp. Ther. 276 1996 1244 1256
43. M.S. Reid, L.B. Ho, K. Hsu, L. Fox, B.K. Tolliver, J.U. Adams, A. Franco, and S.P. Berger Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization Pharmacol. Biochem. Behav. 71 2002 37 54
44. M.C. Ritz, and M.J. Kuhar Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine J. Pharmacol. Exp. Ther. 248 1989 1010 1017
45. A.M. Ronco, P.F. Moraga, and M.N. Llanos Arachidonic acid release from rat Leydig cells: the involvement of G protein, phospholipase A2 and regulation of cAMP production J. Endocrinol. 172 2002 95 104
46. B.M. Ross, N. Mamalias, A. Moszczynska, A.H. Rajput, and S.J. Kish Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease Neuroscience 102 2001 899 904
47. M.S. Shearman, Z. Naor, K. Sekiguchi, A. Kishimoto, and Y. Nishizuka Selective activation of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites FEBS Lett. 243 1989 177 182
48. J. Shinoda, A. Suzuki, Y. Oiso, and O. Kozawa Involvement of phosphatidylcholine hydrolysis by phospholipase D in extracellular ATP-induced arachidonic acid release in aortic smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 17 1997 295 299 (Pubitemid 27098187)
49. I.P. Street, H.K. Lin, F. Laliberte, F. Ghomashchi, Z. Wang, H. Perrier, N.M. Tremblay, Z. Huang, P.K. Weech, and M.H. Gelb Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2 Biochemistry 32 1993 5935 5940
50. J. Sugama, S. Ohkubo, M. Atsumi, and N. Nakahata Mastoparan changes the cellular localization of Galphaq/11 and Gbeta through its binding to ganglioside in lipid rafts Mol. Pharmacol. 68 2005 1466 1474
51. G. Tomlinson Potential misconceptions arising from the application of enzyme kinetic equations to ligand-receptor systems at equilibrium Can. J. Physiol. Pharmacol. 66 1988 342 349
52. A.V. Tzingounis, C.L. Lin, J.D. Rothstein, and M.P. Kavanaugh Arachidonic acid activates a proton current in the rat glutamate transporter EAAT4 J. Biol. Chem. 273 1998 17315 17317
53. D. Vial, and D. Piomelli Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2 J. Neurochem. 64 1995 2765 2772
54. A. Volterra, D. Trotti, P. Cassutti, C. Tromba, R. Galimberti, P. Lecchi, and G. Racagni A role for the arachidonic acid cascade in fast synaptic modulation: ion channels and transmitter uptake systems as target proteins Adv. Exp. Med. Biol. 318 1992 147 158
55. A. Volterra, D. Trotti, and G. Racagni Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms Mol. Pharmacol. 46 1994 986 992
56. R.M. Wightman, and J.B. Zimmerman Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake Brain Res. Rev. 15 1990 135 144
57. H.C. Yang, M. Mosior, C.A. Johnson, Y. Chen, and E.A. Dennis Group-specific assays that distinguish between the four major types of mammalian phospholipase A2 Anal. Biochem. 269 1999 278 288
58. L. Zhang, and M.E. Reith Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway Eur. J. Pharmacol. 315 1996 345 354